Incidence and Outcomes of Desmoplastic Small Round Cell Tumor: Results from the Surveillance, Epidemiology, and End Results Database

por Lettieri, Christina K., Garcia-Filion, Pamela, Hingorani, Pooja
Publicado 2014

Combination immunotherapy with α-CTLA-4 and α-PD-L1 antibody blockade prevents immune escape and leads to complete control of metastatic osteosarcoma

por Lussier, Danielle M, Johnson, John L, Hingorani, Pooja, Blattman, Joseph N
Publicado 2015

Morphological abnormalities in baseline ECGs in healthy normal volunteers participating in phase I studies

por Hingorani, Pooja, Natekar, Mili, Deshmukh, Sheetal, Karnad, Dilip R., Kothari, Snehal, Narula, Dhiraj, Lokhandwala, Yash
Publicado 2012

Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma

por Kahen, Elliot, Yu, Diana, Harrison, Douglas J., Clark, Justine, Hingorani, Pooja, Cubitt, Christopher L., Reed, Damon R.
Publicado 2016

Enhancement of T cell immunity to osteosarcoma through modulation of PD-1/PD-L1 interactions

por Lussier, Danielle M, Nieves, Lizbeth M, McAfee, Megan S, Hyunh, Trung P, Holechek, Susan A, Hingorani, Pooja, Blattman, Joseph N
Publicado 2013

Increased CTLA-4(+) T cells and an increased ratio of monocytes with loss of class II (CD14(+) HLA-DR(lo/neg)) found in aggressive pediatric sarcoma patients

por Hingorani, Pooja, Maas, Mary L., Gustafson, Michael P., Dickman, Paul, Adams, Roberta H., Watanabe, Masayo, Eshun, Francis, Williams, James, Seidel, Matthew J., Dietz, Allan B.
Publicado 2015

ATF6α Activation Enhances Survival against Chemotherapy and Serves as a Prognostic Indicator in Osteosarcoma()()

por Yarapureddy, Suma, Abril, Jazmine, Foote, Janet, Kumar, Saravana, Asad, Omar, Sharath, Veena, Faraj, Janine, Daniel, Dustin, Dickman, Paul, White-Collins, Andrea, Hingorani, Pooja, Sertil, Aparna R
Publicado 2019

Survey of Paediatric Oncologists and Pathologists regarding Their Views and Experiences with Variant Translocations in Ewing and Ewing-Like Sarcoma: A Report of the Children's Onco...

por Kinnaman, Michael D., Zhu, Chong, Weiser, Daniel A., Mohiuddin, Sana, Hingorani, Pooja, Roth, Michael, Gill, Jonathan, Janeway, Katherine A., Gorlick, Richard, Lessnick, Stephen L., Grohar, Patrick J.
Publicado 2020

Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children’s Oncology Group (COG) New Agents for Ewing Sarcoma Task Force

por Bailey, Kelly, Cost, Carrye, Davis, Ian, Glade-Bender, Julia, Grohar, Patrick, Houghton, Peter, Isakoff, Michael, Stewart, Elizabeth, Laack, Nadia, Yustein, Jason, Reed, Damon, Janeway, Katherine, Gorlick, Richard, Lessnick, Stephen, DuBois, Steven, Hingorani, Pooja
Publicado 2019

Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children’s Oncology Group

por Hingorani, Pooja, Dinu, Valentin, Zhang, Xiyuan, Lei, Haiyan, Shern, Jack F., Park, Jin, Steel, Jason, Rauf, Femina, Parham, David, Gastier-Foster, Julie, Hall, David, Hawkins, Douglas S., Skapek, Stephen X., Labaer, Joshua, McEachron, Troy A.
Publicado 2020

Phase 1 trial of olaratumab monotherapy and in combination with chemotherapy in pediatric patients with relapsed/refractory solid and central nervous system tumors

por Mascarenhas, Leo, Ogawa, Chitose, Laetsch, Theodore W., Weigel, Brenda J., Bishop, Michael W., Krystal, Julie, Borinstein, Scott C., Slotkin, Emily K., Muscal, Jodi A., Hingorani, Pooja, Levy, Donna E., Mo, Gary, Shahir, Ashwin, Wright, Jennifer, DuBois, Steven G.
Publicado 2021

Metabolic response as assessed by (18)F‐fluorodeoxyglucose positron emission tomography‐computed tomography does not predict outcome in patients with intermediate‐ or high‐risk rha...

por Harrison, Douglas J., Chi, Yueh‐Yun, Tian, Jing, Hingorani, Pooja, Mascarenhas, Leo, McCowage, Geoffrey B., Weigel, Brenda J., Venkatramani, Rajkumar, Wolden, Suzanne L., Yock, Torunn I., Rodeberg, David A., Hayes‐Jordan, Andrea A., Teot, Lisa A., Spunt, Sheri L., Meyer, William H., Hawkins, Douglas S., Shulkin, Barry L., Parisi, Marguerite T.
Publicado 2020

Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children’s Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force

por Pacenta, Holly L., Allen-Rhoades, Wendy, Langenau, David, Houghton, Peter J., Keller, Charles, Heske, Christine M., Deel, Michael D., Linardic, Corinne M., Shern, Jack F., Stewart, Elizabeth, Turpin, Brian, Harrison, Douglas J., Khan, Javed, Mascarenhas, Leo, Skapek, Stephen X., Meyer, William H., Hawkins, Douglas S., Chen, Eleanor Y., Amatruda, James F., Hingorani, Pooja, Laetsch, Theodore W.
Publicado 2021

Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma

por Wang, Yifei, Tian, Xiangjun, Zhang, Wendong, Zhang, Zhongting, Lazcano, Rossana, Hingorani, Pooja, Roth, Michael E., Gill, Jonathan D., Harrison, Douglas J., Xu, Zhaohui, Jusu, Sylvester, Kannan, Sankaranarayanan, Wang, Jing, Lazar, Alexander J., Earley, Eric J., Erickson, Stephen W., Gelb, Tara, Huxley, Philip, Lahdenranta, Johanna, Mudd, Gemma, Kurmasheva, Raushan T., Houghton, Peter J., Smith, Malcolm A., Kolb, Edward A., Gorlick, Richard
Publicado 2022